January 9, 2024 · Form 4 insider transaction
Mirviss Jeffrey B. bought 15,172 shares of Boston Scientific Corporation at $16.31 per share, a transaction worth $247.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 25, 2023.